Clinical Trial Update: Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed Peripheral T-cell Lymphomas (PTCL) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the oral Fludarabine, Adriamycin (doxorubicin), and Dexamethasone (FAD) regimen for newly diagnosed Peripheral T-cell lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• DEXAMETHASONE (Dexamethasone)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Fudan University | Conditions: T-Cell Lymphomas, Chemotherapy | Phase 2 | Status: UNKNOWN